EQUELLE is a new non-prescription, non-hormonal supplement clinically shown to alleviate the frequency of hot flashes and muscle aches associated with menopause.
 
Approximately 6,000 women in the U.S. reach menopause each day and about 85% of women experience some kind of bothersome symptoms (Woods NF and Mitchell ES. American Journal of Medicine,2005). Hot flashes are the most common menopause symptom and are the second most common in perimenopause. Seventy-five percent of women in the U.S. experience hot flashes.

The active ingredient in EQUELLE is S-equol, which is naturally derived from a plant compound, and shares a similar structure to estrogen and binds to select estrogen receptors in the body. With this bond, S-equol helps alleviate hot flashes and muscle aches associated with menopause.
 
“Thousands of women suffer from menopause symptoms like hot flashes, night sweats, sleep issues, mood changes, vaginal dryness, muscle aches and so much more,” said Tara Allmen, MD, board certified gynecologist and Author of Menopause Confidential. “The exciting news is that there is now a new non-hormonal alternative for women that improves both the frequency of hot flashes and muscle aches associated with menopause.”  
 
Menopause, a natural process that a woman’s body experiences, can take up to seven years. It starts with perimenopause as estrogen production begins to decline and periods become irregular. Once a woman has gone a whole year without a menstrual cycle, she has officially hit menopause. 
 
“We are pleased to launch EQUELLE here in the U.S., after a proven track record in Japan, to address the real needs of women,” stated Dr. Susan Hazels Mitmesser, vice president of science and technology. “We are committed to providing women with nutritional solutions backed by scientific research to help them feel their best during this time of transition.” 
 
Two tablets of EQUELLE should be taken twice daily with a glass of water. In clinical trials, women saw results in as few as four weeks, with optimal results in eight to 12 weeks. EQUELLE has clinical data to support its efficacy and safety. In clinical studies, there were no major adverse events reported. The active ingredient S-equol is affirmed safe in both food and drug supplements (Aso T, Uchiyama S, Matsumura Y et al. Journal of Women’s Health, 2012).